# Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB

> **NCT05494567** · PHASE4 · UNKNOWN · sponsor: **Mansoura University** · enrollment: 60 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia
- Overactive Bladder

## Interventions

- **DRUG:** Tadalafil 5mg
- **DRUG:** Tamsulosin Hcl 0.4 mg
- **DRUG:** solifenacin 10 mg

## Key facts

- **NCT ID:** NCT05494567
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-08
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494567, "Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05494567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*